Psychosocial aspects of resistance in complex treatment of depressive disorder
Language English Country Sweden Media print
Document type Journal Article
PubMed
26454491
PII: NEL360415A08
Knihovny.cz E-resources
- MeSH
- Antidepressive Agents therapeutic use MeSH
- Depressive Disorder, Treatment-Resistant * psychology therapy MeSH
- Depressive Disorder, Major * psychology therapy MeSH
- Adult MeSH
- Outcome Assessment, Health Care * MeSH
- Cognitive Behavioral Therapy MeSH
- Combined Modality Therapy MeSH
- Quality of Life psychology MeSH
- Middle Aged MeSH
- Humans MeSH
- Severity of Illness Index MeSH
- Anxiety psychology MeSH
- Age of Onset MeSH
- Age Factors MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Antidepressive Agents MeSH
OBJECTIVE: Treatment of major depressive disorder can be affected by a broad range of factors. In our study, we focused on the relationships of demographic, psychological, clinical and social factors to the course of treatment of depression. METHOD: The study included 151 patients (finally 140 patients were evaluated) hospitalized for major depressive disorder. They were assessed for demographic characteristics, the rates of depression and anxiety, quality of life, the rates of dissociation and insomnia, and subjective and objective disease severity at different times during treatment. Patients were treated with standard doses of antidepressants or other psychiatric medication. They also completed a 6-week long daily cognitive-behavioural therapy. Data were statistically analyzed. RESULTS: There were significant decreases in the overall severity of the disorder, anxiety level and depression rate during treatment. Improvement measured by objective Clinical Global Impression (oCGI-I) at the end of treatment was not significantly correlated with any of the measured parameters (age of patient, onset of illness, duration of disease, doses of medication etc.). It only significantly positively correlated with the initial evaluation of the patient by oCGI. However, the improvement in subjective assessment (using sCGI-I) correlated with many parameters (increased age, later onset of the disease, greater disease severity at baseline in both overall and subjective evaluation of the severity, anxiety and depressive symptomatology). Furthermore, it was negatively correlated with most quality of life parameters, such as H (Home), F (Feelings), L (Leisure), Sr (Social relations) and G (General). CONCLUSIONS: The results suggest that individual variables, such as the degree of psychopathology, particularly depression and anxiety, most quality of life parameters, higher patient age and age of disorder onset may be associated with poorer subjective response to complex treatment of patients with major depressive disorder.